Some features of the coronavirus infection course in bronchial asthma patients

The outbreak of a new coronavirus infection was officially recognized by the World Health Organization as global pandemic since March 11, 2020. is currently gradually receding, number patients also steadily decreasing. However, these circumstances are not grounds to believe that virus has been definitively and irrevocably defeated. For this reason, world medical community still concerned about impact on course outcome various chronic bronchopulmonary diseases. Bronchial asthma one leading forms human somatic pathology throughout history mankind medicine. It quite natural focus researchers' attention turned out be questions SARS-CoV-2 suffering from bronchial asthma, starting with peculiarities combined ending therapy subsequent rehabilitation. issues pathogenesis were considered. research data some features development in profile analyzed summarized. low prevalence among an allergic form compared other phenotypes shown such features, effect eosinophilia presented, basic therapys positive using inhaled glucocorticosteroids and/or monoclonal antibodies (biological therapy) severe protective provides lighter course. main patient management conditions organization stable control online telemedicine once monthly, regular examinations accordance severity disease correction achieve complete over asthma.